Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Prader-Willi Syndrome
Total 0 results
Nothing found
Sponsors and Collaborators
Everett Meyer
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Aptis Medical
Kupfer, David J., M.D.
Alma Lasers Inc.
Eurofins Genoma
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Mª Victoria Maestre Sanchez
Korean Society of Spine Surgery
Apollo Neuroscience, Inc.
Nacuity Pharmaceuticals, Inc.
RMIT University, Melbourne, Australia
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Neurophth Therapeutics Inc
ASST Cremona, Cremona
Hospital ASEPEYO Sant Cugat
Hospital Durand, Argentina
GFI
iCAD
Agency for Science, Technology and Research
View Full List
Medical Conditions
Metachronous Adenoma
RISS Stage III Plasma Cell Myeloma
Rheumatoid Arthritis(RA)
The Strength Properties of the Aorta in Vitro
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Dienogest
Splenic Trauma
Gastric Cancer Stage IIIB-IIIC
Luteal Phase Support
Corneal Cross-Linking
Immune-Mediated Inflammatory Disease
Major Liver Surgery
Chronic Constipation Symptoms
Scleredema
Treatment Decisions
Recurrent Clear Cell Sarcoma of Soft Tissue
Disorder of Fluid Balance
Fever
T-LGL Leukemia
View Full List
Drug Interventions
Capecitabine/cisplatin
Standard of care (SOC) for COVID-19
Anticholinergic
MLN2480
Intravenous deferiprone
GLPG1837 multiple ascending doses
Fospropofol disodium, propofol
OnabotulinumtoxinA
PD-1/PD-L1 inhibitor
Camptosar
TPN-101
THC
Desvenlafaxine
Oxycodone/acetaminophen 5/325 mg
Intravenous Formulation of PD-0332991
Letrozole
Capecitabine and IMRT (if randomized to this arm)
RDX227675
Midazolam
Olopatadine
View Full List
CROs by country
Contract Research Organizations in Gambia
Contract Research Organizations in Guinea
Contract Research Organizations in Kosovo
Contract Research Organizations in Malawi
Contract Research Organizations in Mozambique
Contract Research Organizations in Norway
Contract Research Organizations in Panama
Contract Research Organizations in Paraguay
Contract Research Organizations in Romania
Contract Research Organizations in United Kingdom
Contract Research Organizations in United States
Contract Research Organizations in Uzbekistan
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Qatar
SGS
All CROs in Qatar
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe